Abo, NM

Drug, Alcohol, DNA Testing Locations

Employment, DOT, Court Ordered, Probation, School, Family

Over 20,000 Local Testing Centers Nationwide

Multiple Testing Centers In Abo, NM

We offer multiple testing services at our local Abo, NM drug testing facilities and the surrounding areas. Our Abo, NM drug testing centers provide same day service for urine drug testing, hair drug testing, alcohol testing, DOT physicals, DOT drug testing and DNA testing. Our drug and alcohol testing services are provided for employers in need of a pre-employment drug test, random drug test, post-accident drug test or reasonable suspicion tests. We also provide testing for individuals needing a drug or alcohol screening for court ordered reasons, probation or family purposes. With testing facilities in all States and Cities, most of our drug testing locations are within minutes of your home or office. Drug testing methods include urine, oral/saliva, hair follicle, blood , ETG and breath alcohol testing. All tests are analyzed by a SAMHSA certified laboratory and verified by our Medical Review Officers. Negative test results are generally available in 24-48 hours. We also provide On-site/mobile drug testing for companies who need to test multiple employees in Abo, NM.

Scheduling a test is Fast and Easy, call our scheduling department or schedule your test online 24/7

*You must register by phone or online to receive your donor pass/registration prior to proceeding to the testing center

Accredited Drug Testing has drug testing locations in most cities and towns throughout the United States. Providing drug testing, alcohol testing, DNA testing and other related services. Most testing centers are within minutes of your home or office. Same day service is available in most cases. To schedule a test please call our scheduling department at 1-800-221-4291 or you may schedule your test online utilizing your zip code in which you are located.

Employers - Accredited Drug Testing provides easy, convenient, confidential and cost-effective drug testing services, including pre-employment drug testing, random drug testing, post-accident drug testing and reasonable suspicion drug and alcohol testing. We can also assist you with the implementation of your drug free workplace program with drug policy development, supervisor training, employee education and on-going consultation. In many cases a company certified as a drug free workplace can receive discounts on their workers' compensation insurance premiums along with lowering employee absenteeism, enhancing workplace safety and improving employee morale. To open a no cost employer drug testing account click here or call our office at 1-800-221-4291

Individuals - If you are an individual in need of a drug, alcohol or DNA test, Accredited Drug Testing is your one stop shopping for all your testing needs. Simply call our customer service staff at 1-800-221-4291 or you may register online. There is no need to open an account or be affiliated with any company. Accredited Drug Testing offers drug testing for personal, court ordered, probation, child custody or any other reason you may need! To schedule a test please call our scheduling department at 1-800-221-4291 or you may schedule your test online utilizing your zip code in which you are located.

Abo, NM Drug Testing Locations

(Don’t see a location near you, call 800-221-4291)

Search Locations by State

"When You Need A Test, Choose The Best"
Enter your Zip Code For A Location Near You

Zip Code
Radius
 

Local Area Info: ABO (gene)

Histo-blood group ABO system transferase is an enzyme with glycosyltransferase activity, which is encoded by the ABO gene in humans. It is ubiquitously expressed in many tissues and cell types. ABO determines the ABO blood group of an individual by modifying the oligosaccharides on cell surface glycoproteins. Variations in the sequence of the protein between individuals determine the type of modification and the blood group. The ABO gene also contains one of 27 SNPs associated with increased risk of coronary artery disease.

The ABO gene resides on chromosome 9 at the band 9q34.2 and contains 7 exons. The ABO locus encodes three alleles. The A allele produces ?-1,3-N-acetylgalactosamine transferase (A-transferase), which catalyzes the transfer of GalNAc residues from the UDP-GalNAc donor nucleotide to the Gal residues of the acceptor H antigen, converting the H antigen into A antigen in A and AB individuals. The B allele encodes ?-1,3-galactosyl transferase (B-transferase), which catalyzes the transfer of Gal residues from the UDP-Gal donor nucleotide to the Gal residues of the acceptor H antigen, converting the H antigen into B antigen in B and AB individuals. Remarkably, the difference between the A and B glycosyltransferase enzymes is only four amino acids. The O allele lacks both enzymatic activities because of the frame shift caused by a deletion of guanine-258 in the gene which corresponds to a region near the N-terminus of the protein.This results in a frameshift and translation of an almost entirely different protein. This mutation results in a protein unable to modify oligosaccharides which end in fucose linked to galactose. Thus no A or B antigen is found in O individuals. This sugar combination is termed the H antigen. These antigens play an important role in the match of blood transfusion and organ transplantation. Other minor alleles have been found for this gene.

In human cells, the ABO alleles and their encoded glycosyltransferases have been described in several oncologic conditions. Using anti-GTA/GTB monoclonal antibodies, it was demonstrated that a loss of these enzymes was correlated to malignant bladder and oral epithelia. Furthermore, the expression of ABO blood group antigens in normal human tissues is dependent the type of differentiation of the epithelium. In most human carcinomas, including oral carcinoma, a significant event as part of the underlying mechanism is decreased expression of the A and B antigens. Several studies have observed that a relative down-regulation of GTA and GTB occurs in oral carcinomas in association with tumor development. More recently, a genome wide association study (GWAS) has identified variants in the ABO locus associated with susceptibility to pancreatic cancer.